Correction of Figure Error in Clinical Trial Delivery Study

Background

Accurate representation of data in clinical trials is crucial for the integrity of research findings. Errors in figures can lead to misinterpretations that affect clinical decision-making and policy development.

Data Highlights

No numerical data is presented in this correction notice.

Key Findings

• The original investigation was published on July 2, 2025.
• An error was identified in Figure 1, Panel C, regarding the comparison period.
• The corrected comparison is between UK and non-UK countries during the COVID-19 pandemic.
• The correction was officially issued on July 16, 2026.
• Details of the correction are documented in the article’s figure captions and correction notice.

Clinical Implications

Clinicians and researchers should ensure that data representations in clinical trials are accurate to avoid misinterpretation. Continuous monitoring and correction of published data are essential for maintaining the credibility of clinical research.

Conclusion

The correction serves as a reminder of the importance of accuracy in clinical trial reporting and the need for ongoing scrutiny of published research.

Related Resources & Content

1. JAMA Network Open, 2025 -- Hurdles for the Delivery of Multinational Randomized Clinical Trials
2. JAMA Dermatology — Errors in the Table 2
3. npj Digital Medicine — Correction Notice: Optimal Guidelines and Factors for Creating and Digitally Executing Event-Driven Diaries in Clinical Research
4. Bone Marrow Transplantation — Designing Clinical Trials: Key Endpoints and Outcome Interpretation
5. The Journal of Clinical Endocrinology & Metabolism — Erratum for: “Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: Results from the 52-Week Phase 3 PaTHway Study”
6. EMA Management Board: highlights of June 2026 meeting
7. E6(R3) Good Clinical Practice (GCP)
8. Hurdles for the Delivery of Multinational Randomized Clinical Trials | Infectious Diseases | JAMA Network Open | JAMA Network